| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
Afeyan Noubar is a Director, 10% Owner at Seres Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 67 sells.
Estimated insider holdings value: $31.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 25, 2022 | MRNA Moderna, Inc. | Director | Sell | 10,000 | $130.80 | $1,308,000.00 | -0.4% | +9.9% | -3.3% | |
| May 18, 2022 | MRNA Moderna, Inc. | Director | Sell | 10,000 | $138.38 | $1,383,800.00 | -0.4% | +22.0% | -9.0% | |
| May 13, 2022 | MRNA Moderna, Inc. | Director | Sell | 310,000 | $131.79 | $40,855,185.59 | -0.6% | +24.6% | -6.2% | |
| Mar 31, 2021 | MRNA Moderna, Inc. | Director | Sell | 3,752,805 | $121.43 | $455,692,554.21 | -1.9% | +79.0% | +31.5% | |
| Feb 24, 2021 | MRNA Moderna, Inc. | Director | Sell | 1,753,697 | $146.19 | $256,378,924.05 | -1.8% | - | - | |
| Feb 23, 2021 | MRNA Moderna, Inc. | Director | Sell | 4,784,404 | $152.59 | $730,069,590.44 | -1.0% | - | - | |
| Jun 18, 2019 | MCRB Seres Therapeutics, Inc. | Director, 10% Owner | Buy | 8,888,888 | $2.25 | $19,999,998.00 | New | - | - | |
| May 25, 2016 | MCRB Seres Therapeutics, Inc. | Director, 10% Owner | Sell | 1,000,000 | $27.60 | $27,600,000.00 | -17.7% | - | - |